Name: | heptabarbital |
---|---|
PubChem Compound ID: | 10518 |
Molecular formula: | C13H18N2O3 |
Molecular weight: | 250.294 g/mol |
Synonyms: |
5-(1-CYCLOHEPTEN-1-YL)-5-ETHYLBARBITURIC ACID; Medapan; Eudan; Noctyn; Heptbarbital; Heptabarbo [INN-Spanish]; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohepten-1-yl)-5-ethyl- (9CI); 5-Ethyl-5-(1'-cycloheptenyl)-barbituric acid; Cycloheptenylethylbarbituric acid; Heptabarb.
show more » |
Name: | heptabarbital |
---|---|
Name (isomeric): | DB01354 |
Drug Type: | small molecule |
Synonyms: |
Medapan; Heptamalum; Heptamal; Medomine; Heptbarbital; Heptabarb; Heptadorm; Heptabarbum; Heptabarbitone
|
Category: | Hypnotics and Sedatives, Barbiturates |
CAS number: | 509-86-4 |
Indication: | Used mainly for sedation and hypnosis. |
---|---|
Mechanism of Action: |
Heptabarbital (like all barbiturates) works by binding to the GABAA receptor at either the alpha or the beta sub unit. These are binding sites that are distinct from GABA itself and also distinct from the benzodiazepine binding site. Like benzodiazepines, barbiturates potentiate the effect of GABA at this receptor. This GABAA receptor binding decr...
show more » |
Biotransformation: | Hepatic. |
Toxicity: | Symptoms of an overdose typically include sluggishness, incoordination, difficulty in thinking, slowness of speech, faulty judgment, drowsiness or coma, shallow breathing, staggering, and in severe cases coma and death. |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|